- Report
- April 2025
- 250 Pages
Global
From €5369EUR$5,600USD£4,486GBP
- Report
- November 2024
- 168 Pages
Global
From €2397EUR$2,500USD£2,003GBP
- Report
- February 2025
- 185 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- June 2024
- 200 Pages
Global
From €7621EUR$7,950USD£6,368GBP
- Report
- January 2022
- 60 Pages
Global
From €3787EUR$3,950USD£3,164GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1198EUR$1,250USD£1,001GBP
- Report
- August 2024
- 85 Pages
United Kingdom
From €3355EUR$3,500USD£2,804GBP
Smallpox is a highly contagious and potentially fatal infectious disease caused by the variola virus. Smallpox was declared eradicated in 1980, however, the threat of a bioterrorist attack using the virus has led to the development of drugs to treat the disease.
The smallpox drug market is a subset of the infectious diseases drugs market. It includes drugs used to treat smallpox, as well as vaccines to prevent it. Vaccines are the primary form of prevention, but antiviral drugs are also used to treat the disease. These drugs work by targeting the virus and preventing it from replicating.
The smallpox drug market is highly competitive, with several companies developing drugs and vaccines. These include GlaxoSmithKline, Merck, Pfizer, Sanofi, and Johnson & Johnson. Show Less Read more